Stay updated on CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial
Sign up to get notified when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.

Latest updates to the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page
- Check2 days agoNo Change Detected
- Check9 days agoNo Change Detected
- Check16 days agoNo Change Detected
- Check23 days agoChange DetectedThe page has removed a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products.SummaryDifference2%
- Check31 days agoNo Change Detected
- Check38 days agoChange DetectedThe page now includes a notice regarding heavy traffic affecting the performance and availability of some NLM-NCBI services and products, along with a contact email for assistance.SummaryDifference2%
- Check45 days agoChange DetectedThe website has been updated from version v2.14.1 to v2.14.2.SummaryDifference0.1%
- Check59 days agoChange DetectedThe website has been updated from version 2.14.0 to 2.14.1.SummaryDifference0.1%
- Check66 days agoChange DetectedThe website has updated its study details, including a new termination status and a revised plan for sharing individual participant data, while removing previous intervention types and estimated dates.SummaryDifference4%
- Check96 days agoChange DetectedThe website has been updated from version 2.13.2 to 2.13.3.SummaryDifference0.1%
Stay in the know with updates to CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial
Enter your email address, and we'll notify you when there's something new on the CTX120 in RR Multiple Myeloma: Safety and Efficacy Clinical Trial page.